MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences and drug discovery and development fields. Their special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas. As a JSR Life Sciences Company, MBLI is committed to improve the probability of success, decrease timelines, and increase the efficacy of biologics-based therapies for the benefit of patients.
Headquartered in Woburn, MA, with a manufacturing location in Des Plaines, IL, MBLI’s extensive global distribution network spans over 50 countries to ensure timely delivery of products and services.
MBLI's products are used widely in academic research and medical institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories. They are focused on developing high quality products and have high standards for quality control in their manufacturing process. Their products include MHC monomers and multimers, antibodies, recombinant proteins, fluorescent proteins, and ELISA kits. Their products are highly cited and support numerous research fields relating to oncology, allergy, apoptosis, autophagy, epigenetics and neuroscience.
MBLI is known for its line of immune monitoring reagents, including MHC Tetramers and Monomers, as well as their line of QuickSwitch™ products for screening peptides and neoantigens. They help researchers to acquire reliable and reproducible immune monitoring results for the areas of immuno-oncology, autoimmune, vaccine development and more.